BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 14978873)

  • 21. Endoglin expression is associated with poor oncologic outcome in oral and oropharyngeal carcinoma.
    Marioni G; Marino F; Giacomelli L; Staffieri C; Mariuzzi ML; Violino E; De Filippis C
    Acta Otolaryngol; 2006 Jun; 126(6):633-9. PubMed ID: 16720449
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endoglin (CD105) is expressed on immature blood vessels and is a marker for survival in prostate cancer.
    Wikström P; Lissbrant IF; Stattin P; Egevad L; Bergh A
    Prostate; 2002 Jun; 51(4):268-75. PubMed ID: 11987155
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative prognostic relevance of breast intra-tumoral microvessel density evaluated by CD105 and CD146: A pilot study of 42 cases.
    Martinez LM; Labovsky V; Calcagno Mde L; Davies KM; Rivello HG; Wernicke A; Calvo JC; Chasseing NA
    Pathol Res Pract; 2016 Apr; 212(4):350-5. PubMed ID: 26872535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The risk of developing metastatic disease in colorectal cancer is related to CD105-positive vessel count.
    Romani AA; Borghetti AF; Del Rio P; Sianesi M; Soliani P
    J Surg Oncol; 2006 May; 93(6):446-55. PubMed ID: 16615157
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Relevance of Endoglin (CD105) VEGF and p53 with invasion metastasis and prognosis of laryngeal carcinoma].
    Li Q; Zhang B; Peng P
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Dec; 21(24):1114-7. PubMed ID: 18330257
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endoglin (CD 105) as a potential prognostic factor in neuroblastoma.
    Ćavar S; Jelašić D; Seiwerth S; Milošević M; Hutinec Z; Mišić M
    Pediatr Blood Cancer; 2015 May; 62(5):770-5. PubMed ID: 25683142
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vascularization in primary breast carcinomas: its prognostic significance and relationship with tumor cell dissemination.
    Dhakal HP; Naume B; Synnestvedt M; Borgen E; Kaaresen R; Schlichting E; Wiedswang G; Bassarova A; Giercksky KE; Nesland JM
    Clin Cancer Res; 2008 Apr; 14(8):2341-50. PubMed ID: 18413823
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of neovasculature in uveal melanoma by targeting the TGFbeta-binding receptor endoglin: is there prognostic relevance of proliferating endothelium?
    Ziemssen F; Wegner R; Wegner J; Tatar O; Süsskind D; Gelisken F; Rohrbach M; Bartz-Schmidt KU; Grisanti S
    Graefes Arch Clin Exp Ophthalmol; 2006 Sep; 244(9):1124-31. PubMed ID: 16523306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microvessel density assessment in benign and malignant endometrial changes.
    Czekierdowski A; Czekierdowska S; Czuba B; Cnota W; Sodowski K; Kotarski J; Zwirska-Korczala K
    J Physiol Pharmacol; 2008 Sep; 59 Suppl 4():45-51. PubMed ID: 18955753
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic significance of microvessel density determined by an anti-CD105/endoglin monoclonal antibody in astrocytic tumors: comparison with an anti-CD31 monoclonal antibody.
    Yao Y; Kubota T; Takeuchi H; Sato K
    Neuropathology; 2005 Sep; 25(3):201-6. PubMed ID: 16193836
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endoglin (CD105) expression in angiogenesis of primary hepatocellular carcinomas: analysis using tissue microarrays and comparisons with CD34 and VEGF.
    Yao Y; Pan Y; Chen J; Sun X; Qiu Y; Ding Y
    Ann Clin Lab Sci; 2007; 37(1):39-48. PubMed ID: 17311868
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microvessel Landscape Assessment in Pancreatic Ductal Adenocarcinoma: Unclear Value of Targeting Endoglin (CD105) as Prognostic Factor of Clinical Outcome.
    Lytras D; Leontara V; Kefala M; Foukas PG; Giannakou N; Pouliakis A; Dervenis C; Panayiotides IG; Karakitsos P
    Pancreas; 2015 Jan; 44(1):87-92. PubMed ID: 25058886
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunohistochemical evaluation of the microvascular density through the expression of TGF-beta (CD 105/endoglin) and CD 34 receptors and expression of the vascular endothelial growth factor (VEGF) in oligodendrogliomas.
    Netto GC; Bleil CB; Hilbig A; Coutinho LM
    Neuropathology; 2008 Feb; 28(1):17-23. PubMed ID: 18181830
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of angiogenesis in non-small cell lung cancer: comparison between anti-CD34 antibody and anti-CD105 antibody.
    Tanaka F; Otake Y; Yanagihara K; Kawano Y; Miyahara R; Li M; Yamada T; Hanaoka N; Inui K; Wada H
    Clin Cancer Res; 2001 Nov; 7(11):3410-5. PubMed ID: 11705856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD105 is a marker of tumour vasculature and a potential target for the treatment of head and neck squamous cell carcinoma.
    Marioni G; D'Alessandro E; Giacomelli L; Staffieri A
    J Oral Pathol Med; 2010 May; 39(5):361-7. PubMed ID: 20537053
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinicopathologic significance of CD105 expression in squamous cell carcinoma of the hypopharynx.
    Chien CY; Su CY; Hwang CF; Chuang HC; Hsiao YC; Wu SL; Huang CC
    Head Neck; 2006 May; 28(5):441-6. PubMed ID: 16320363
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of the prognostic significance of endoglin (CD105) in clear cell renal cell carcinoma using automated image analysis.
    Dubinski W; Gabril M; Iakovlev VV; Scorilas A; Youssef YM; Faragalla H; Kovacs K; Rotondo F; Metias S; Arsanious A; Plotkin A; Girgis AH; Streutker CJ; Yousef GM
    Hum Pathol; 2012 Jul; 43(7):1037-43. PubMed ID: 22204709
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiangiogenic therapy of established tumors in human skin/severe combined immunodeficiency mouse chimeras by anti-endoglin (CD105) monoclonal antibodies, and synergy between anti-endoglin antibody and cyclophosphamide.
    Takahashi N; Haba A; Matsuno F; Seon BK
    Cancer Res; 2001 Nov; 61(21):7846-54. PubMed ID: 11691802
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of serum endoglin with metastasis in patients with colorectal, breast, and other solid tumors, and suppressive effect of chemotherapy on the serum endoglin.
    Takahashi N; Kawanishi-Tabata R; Haba A; Tabata M; Haruta Y; Tsai H; Seon BK
    Clin Cancer Res; 2001 Mar; 7(3):524-32. PubMed ID: 11297243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative evaluation of microvessel density determined by CD34 or CD105 in benign and malignant gastric lesions.
    Ding S; Li C; Lin S; Yang Y; Liu D; Han Y; Zhang Y; Li L; Zhou L; Kumar S
    Hum Pathol; 2006 Jul; 37(7):861-6. PubMed ID: 16784986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.